Report of an Iranian Child with Chronic Abdominal Pain and Constipation Diagnosed As Glycogen Storage Disease Type IX: a Case Report

Overview

Journal J Med Case Rep

Publisher Biomed Central

Specialty General Medicine

Date 2024 Jan 11

PMID 38212860

Authors

Daniel Zamanfar

Seyed MohammadBagher Hashemi-Soteh

Mobin Ghazaiean

Elham Keyhanian

Affiliations

Soon will be listed here.

Abstract

Background: Glycogen storage disease type IX is a rare disorder that can cause a wide variety of symptoms depending on the specific deficiency of the phosphorylase kinase enzyme and the organs it affects.

Case Presentation: A 4-and-a-half-year-old Caucasian girl was referred to our clinic with a liver biopsy report indicating a diagnosis of glycogen storage disease. Prior to being referred to our clinic, the patient had been under the care of pediatric gastroenterologists. The patient's initial symptoms included chronic abdominal pain, constipation, and elevated liver transaminase. With the help of the pediatric gastroenterologists, cholestasis, Wilson disease, and autoimmune hepatitis were ruled out. Given that glycogen storage diseases type I and type III are the most common, we initially managed the patient with frequent feedings and a diet that included complex carbohydrates such as a corn starch supplement and a lactose restriction. Following an unfavorable growth velocity and hepatomegaly during the follow-up period, genetic analysis was conducted, which revealed a novel mutation of the phosphorylase kinase regulatory subunit beta gene- a c.C412T (P.Q138x) mutation. As the diagnosis of glycogen storage disease type IX was confirmed, the treatment regimen was altered to a high protein diet (more than 2 g/kg/day) and a low fat diet.

Conclusion: Given the mild and varied clinical manifestations of glycogen storage disease type IX, it is possible for the diagnosis to be overlooked. It is important to consider glycogen storage disease type IX in children who present with unexplained hepatomegaly and elevated transaminase levels. Furthermore, due to the distinct management of glycogen storage disease type IX compared with glycogen storage disease type I and glycogen storage disease type III, genetic analysis is essential for an accurate diagnosis.

References

Kim J, Kim J, Lee B, Kim G, Shin Y, Yoo H . Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly. Pediatr Gastroenterol Hepatol Nutr. 2015; 18(2):138-43. PMC: 4493248. DOI: 10.5223/pghn.2015.18.2.138. View

Rodriguez-Jimenez C, Santos-Simarro F, Campos-Barros A, Camarena C, Lledin D, Vallespin E . A new variant in is associated with glycogen storage disease type IXa. Mol Genet Metab Rep. 2017; 10:52-55. PMC: 5233919. DOI: 10.1016/j.ymgmr.2017.01.003. View

Schippers H, Smit G, Rake J, Visser G . Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX). J Inherit Metab Dis. 2003; 26(1):43-7. DOI: 10.1023/a:1024071328772. View

Tuchman M, Brown B, Burke B, Ulstrom R . Clinical and laboratory observations in a child with hepatic phosphorylase kinase deficiency. Metabolism. 1986; 35(7):627-33. DOI: 10.1016/0026-0495(86)90169-1. View

Burwinkel B, Maichele A, Aagenaes O, Bakker H, Lerner A, Shin Y . Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). Hum Mol Genet. 1997; 6(7):1109-15. DOI: 10.1093/hmg/6.7.1109. View

Burda P, Hochuli M . Hepatic glycogen storage disorders: what have we learned in recent years?. Curr Opin Clin Nutr Metab Care. 2015; 18(4):415-21. DOI: 10.1097/MCO.0000000000000181. View

Zhang J, Yuan Y, Ma M, Liu Y, Zhang W, Yao F . Clinical and genetic characteristics of 17 Chinese patients with glycogen storage disease type IXa. Gene. 2017; 627:149-156. DOI: 10.1016/j.gene.2017.06.026. View

Kishnani P, Goldstein J, Austin S, Arn P, Bachrach B, Bali D . Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019; 21(4):772-789. DOI: 10.1038/s41436-018-0364-2. View

Erez A, Shchelochkov O, Plon S, Scaglia F, Lee B . Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism. Am J Hum Genet. 2011; 88(4):402-21. PMC: 3071916. DOI: 10.1016/j.ajhg.2011.03.005. View

10.

Choi R, Park H, Kang B, Choi S, Ki C, Lee S . PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations. BMC Med Genet. 2016; 17:33. PMC: 4839068. DOI: 10.1186/s12881-016-0295-1. View

11.

Davit-Spraul A, Piraud M, Dobbelaere D, Valayannopoulos V, Labrune P, Habes D . Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. Mol Genet Metab. 2011; 104(1-2):137-43. DOI: 10.1016/j.ymgme.2011.05.010. View

12.

Wolfsdorf J, Weinstein D . Glycogen storage diseases. Rev Endocr Metab Disord. 2003; 4(1):95-102. DOI: 10.1023/a:1021831621210. View

13.

Byrne B, Falk D, Pacak C, Nayak S, Herzog R, Elder M . Pompe disease gene therapy. Hum Mol Genet. 2011; 20(R1):R61-8. PMC: 3095055. DOI: 10.1093/hmg/ddr174. View

14.

Melis D, Pivonello R, Parenti G, Casa R, Salerno M, Lombardi G . Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. J Pediatr. 2007; 150(3):300-5, 305.e1. DOI: 10.1016/j.jpeds.2006.11.056. View

15.

Willems P, Gerver W, Berger R, Fernandes J . The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur J Pediatr. 1990; 149(4):268-71. DOI: 10.1007/BF02106291. View

16.

Tsilianidis L, Fiske L, Siegel S, Lumpkin C, Hoyt K, Wasserstein M . Aggressive therapy improves cirrhosis in glycogen storage disease type IX. Mol Genet Metab. 2013; 109(2):179-82. PMC: 3672367. DOI: 10.1016/j.ymgme.2013.03.009. View

17.

Fernandes J, PIKAAR N . Ketosis in hepatic glycogenosis. Arch Dis Child. 1972; 47(251):41-6. PMC: 1647981. DOI: 10.1136/adc.47.251.41. View

18.

Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J . The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada. Mol Genet Metab. 2014; 113(3):171-6. DOI: 10.1016/j.ymgme.2014.09.005. View

19.

Johnson A, Goldstein J, Bali D . Glycogen storage disease type IX: novel PHKA2 missense mutation and cirrhosis. J Pediatr Gastroenterol Nutr. 2011; 55(1):90-2. DOI: 10.1097/MPG.0b013e31823276ea. View